Contact this trialFirst, we need to learn more about you.
5-HT3 Receptor Antagonist
Ondansetron for Sleep Fainting
Recruiting1 awardPhase 3
Calgary, Alberta
This trial will test if anti-nausea medication can prevent syncope in patients with Sleep Syncope who awaken with nausea. It could lead to the first effective treatment & understanding of brain-initiated syncope in the community. #MedicalResearch #Syncope
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.